Business
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that, further to its press release dated January 2, 2026, it now anticipates to list on NYSE American on or around January 30, 2026, subject to approval of its listing application and continued compliance with exchange rules." subject to authorization of the application and continu
About this update from Summit Hotel Properties, Inc.
[{"type":"text","content":"HERZLIYA, Israel and CALGARY, AB, Jan. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that, further to its press release dated January 2, 2026, it now anticipates to list on NYSE American on or around January 30, 2026, subject to approval of its listing application and continued compliance with exchange rules." subject to authorization of the application and continued compliance with the exchange rules.","length":627,"tagName":"p"},{"type":"image","alt":"Innocan Pharma Corporation Logo","displaySize":"","headline":null,"caption":"Innocan Pharma Corporation Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":283,"url":"https://media.zenfs.com/en/cnwgroup.com/832687582b3cafbf2c17967ecc507302"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Kto6KvZV6wm4tNfN4.0jIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ5OTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/832687582b3cafbf2c17967ecc507302","width":400,"height":283}}},{"type":"text","content":"In connection with the anticipated NYSE listing, Innocan is also conducting a concurrent offering of its securities, subject to market conditions and regulatory approval (the "Offering"). Additional details regarding the Offering will be provided through the Company's filings with the Securities and Exchange Commission ("SEC") and SEDAR+.","length":364,"tagName":"p"},{"type":"text","content":"Innocan expects that its common shares will continue to trade on the OTC Markets' OTCQB until the close of the market on or about January 29, 2026. Upon effectiveness of the listing on the NYSE American, trading of the common shares on the OTCQB will terminate. Stockholders of Innocan do not need to take any action prior to the listing of Innocan's shares on the NYSE American. Innocan's common shares will continue to trade on the Canadian Securities Exchange (CSE) under the symbol "INNO".","length":515,"tagName":"p"},{"type":"text","content":"This communication does not constitute an offer, or a solicitation of an offer, to buy or sell any securities, investment or other specific product, or a solicitatio...